A class of oral glucose-lowering drugs that act by closing ATP-dependent potassium channels in pancreatic beta cells, thus causing calcium channel opening and subsequent insulin release.
As scientists who evolve with technology we treat innovation as a way of life, a life we dedicate to improvement and advancement of Safety, Health and Environment.
